3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
6
Melanoma
6
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Mouth Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Neoplasms
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Dysplasia
2
Skin Neoplasms
2
Sarcoma, Kaposi
2
Sarcoma
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Inflammatory Breast Neoplasms
2
HIV Infections
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Turcot syndrome
1
Thrombocytosis
1
Interventions
Cyclophosphamide
9
fludarabine
8
Interleukin-2
8
aldesleukin
7
Sunitinib
6
Everolimus
6
Bevacizumab
6
fludarabine phosphate
5
Sorafenib
5
Radiotherapy
4
Nivolumab
4
Gene Expression Profiling
4
Filgrastim
4
pembrolizumab
3
peginterferon alfa-2b
3
Stem Cell Transplantation
3
Radiotherapy, Intensity-Modulated
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Immunohistochemistry
3
Granulocyte Colony-Stimulating Factor
3
cabozantinib
2
atezolizumab
2
Thiotepa
2
Sodium Chloride
2
Reverse Transcriptase Polymerase Chain Reaction
2
Polymerase Chain Reaction
2
Mycophenolic Acid
2
Mesna
2
Immunoenzyme Techniques
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Kidney Neoplasms
×
Biopsy
×
Clear all
NCT06264479
2025-07-30
PEAR-TREE2
Ourotech, Inc.
Terminated
7 enrolled